Welcome to our dedicated page for PROGRESSIVE CARE news (Ticker: RXMD), a resource for investors and traders seeking the latest updates and insights on PROGRESSIVE CARE stock.
Overview of Progressive Care Inc. (RXMD)
Progressive Care Inc. operates as a specialized healthcare services organization based in South Florida. Through its subsidiaries, Smart Medical Alliance, Inc. and Pharmco, LLC, the company delivers a broad suite of health solutions that include third-party administration, data management, tele-pharmacy services, and comprehensive 340B contracted pharmacy services. With a focus on personalized care, Progressive Care addresses the evolving needs of patients, healthcare providers and long-term care facilities by ensuring efficient prescription pharmaceutical services and tailored practice management solutions.
Core Service Offerings
The company is dedicated to providing an integrated range of services and solutions designed to enhance operational efficiencies and patient care standards. Key service areas include:
- Tele-Pharmacy: Enabled by advanced technology platforms, Progressive Care offers remote pharmacy services that ensure continuous support to patients and providers alike.
- 340B Contracted Pharmacy Services: The company robustly manages 340B contracts to facilitate cost-effective medication therapy management and compliance for covered entities.
- Third-Party Administration (TPA): With expertise in practice management, the company provides data management and billing services tailored to the healthcare environment.
- Risk Management & Quality Assurance: Progressive Care implements comprehensive risk and quality management protocols to safeguard patient care and enhance operational reliability.
- Prescription Management: Through its PharmcoRx pharmacies, the company ensures the supply, dispensing, and management of prescription pharmaceuticals and compounded medications.
Industry Position and Integrated Approach
Progressive Care Inc. has established itself as a critical player within the healthcare services sector. Its operations are strategically positioned to support the growing complexity of modern healthcare through:
- Comprehensive Care Integration: The seamless integration of tele-pharmacy, medication therapy management, and third-party administration enhances both care delivery and patient adherence.
- Data-Driven Excellence: The company leverages advanced data management and EHR implementation techniques to optimize billing, coding, and overall practice management processes.
- Robust Regulatory Compliance: By focusing on stringent risk management protocols, Progressive Care maintains high standards in quality assurance and compliance within the dynamic healthcare regulatory landscape.
Operational Dynamics and Strategic Insights
Progressive Care Inc. operates in a sector marked by rapid technological evolution and escalating patient expectations. The company generates revenue primarily through comprehensive service contracts, prescription sales, and management fees associated with its 340B contracted pharmacy services. Its emphasis on personalized and quality-driven care distinguishes it in a competitive environment populated by similar healthcare providers.
Relationship with NextPlat Corp
In recent developments, Progressive Care became a subsidiary of NextPlat Corp. This strategic alignment has positioned Progressive Care to benefit from further resource integration and shared efficiencies, while continuing to deliver specialized healthcare solutions. The business combination with NextPlat reinforces Progressive Care's ability to scale its operations and extend its market reach in the technology-driven healthcare and prescription management spheres.
Commitment to Quality and Patient Care
The company demonstrates a steadfast commitment to improving patient outcomes through innovative service delivery and enhanced access to quality care. Whether it is managing large-scale 340B programs or providing tele-pharmacy services that bridge the gap between patients and healthcare providers, Progressive Care Inc. continues to build trust among its stakeholders by maintaining the highest standards of expertise, experience, and operational transparency.
Progressive Care (OTCQB: RXMD) announced the retention of ClearThink Capital for investor outreach to enhance stockholder value. The company has filed an S-1 Registration Statement aiming for Nasdaq listing, signaling readiness for growth. CEO Alan Jay Weisberg emphasized improving patient services, leading to revenue growth and better cash flow. ClearThink aims to connect RXMD with institutional investors, emphasizing its compelling investment proposition based on its unique business model and improved financials. The strategic partnership aims to elevate RXMD's investor relations and broaden its audience.
Progressive Care Inc. (OTCQB: RXMD) announced the donation of 1,000 Thanksgiving turkeys to local residents in need. CEO Alan Jay Weisberg highlighted the logistical efforts involved in the initiative, aiming to support families reconnecting after the COVID-19 pandemic. The Company's commitment to community assistance is underscored by this donation, which addresses challenges stemming from supply chain disruptions in the poultry industry. Progressive Care emphasizes its role in enhancing community well-being through its charitable efforts.
Progressive Care Inc. (OTCQB: RXMD) reported significant financial growth for Q3 2021, with net income increasing by 137% year-over-year. EBITDA rose 136% during the same period, reaching nearly $695k. Consolidated net revenues reached $9.8 million for the quarter, while gross margins improved to 30%, up from 27% in Q3 2020. The company attributed success to its 340B pharmacy services, third-party administration, and COVID-19 testing. Progressive Care is also pursuing a NASDAQ uplist through a filed registration statement on Form S-1.
Progressive Care Inc. (OTCQB: RXMD) announced an investor conference call scheduled for November 15, 2021, at 4:30 PM ET. CEO Alan Jay Weisberg described the third quarter as challenging yet productive, with the successful deployment of a new pharmacy system and record revenues from COVID-19 testing. The company has partnered with The Benchmark Company for investment banking services, aiming for a Nasdaq listing. Attendees can submit questions for the call, and a replay will be available post-event.
Progressive Care Inc. (OTCQB:RXMD) reported a solid financial performance for Q2 and first half of 2021, with consolidated revenue of approximately $9.6 million for the quarter and $19.2 million for six months, marking year-over-year increases of 4% and 5%, respectively. Gross profits surged to over $2.6 million for Q2, a 43% rise from 2020. The 340B revenue climbed by 65% year-over-year to about $725k, while COVID testing revenue soared by over 120%. Positive EBITDA of nearly $78k was achieved in Q2, compared to a loss of $311k in 2020. Challenges included temporary prescription volume setbacks due to tech transition and workforce shortages.
Progressive Care Inc. (OTCQB: RXMD) announced an investor conference call scheduled for August 16, 2021, at 4:30 PM ET. The call aims to share operating results and discuss the company's role in combating COVID-19 through a technology-driven healthcare ecosystem that provides vaccinations and testing resources. CEO Alan Jay Weisberg highlighted the importance of these services for compliance and risk mitigation in data-driven healthcare settings. Questions for the call can be submitted until August 13, 2021.
Progressive Care Inc. (OTCQB:RXMD) has launched the myVax Passport app, developed with EagleForce Health, to enhance COVID-19 testing and vaccination data management. The app allows PharmCoRx to securely upload and store users' data, automatically reporting it to the Florida Department of Health. Patients benefit from contactless testing and swift result delivery, with nearly 10,000 tests administered in the first half of 2021. The service aims to simplify health record storage and includes future telehealth capabilities, positioning Progressive Care as a leader in digital health services.
Progressive Care Inc. (OTCQB: RXMD) has announced that it is now accepting Bitcoin for COVID-19 Rapid Testing services at its PharmcoRx locations. CEO Alan Jay Weisberg stated this initiative aims to cater to post-pandemic tourists and those choosing alternative payment methods. The decision coincides with a major Bitcoin conference attracting over 50,000 visitors in Miami. PharmcoRx has conducted over 10,000 COVID-19 tests, generating over $1 million in testing revenues. This move enhances accessibility for Bitcoin users seeking essential testing services.
Progressive Care Inc. (OTCQB: RXMD) has announced that its Board decided against proceeding with a reverse stock split, which was approved by shareholders in December 2020. The split was intended to facilitate a national exchange listing and attract institutional investors. However, due to unfavorable market conditions and the nearing expiration of the Board's authority, the timing was deemed inappropriate. The company remains focused on becoming an SEC-reporting issuer and aims to complete its uplist to a national exchange.
Progressive Care, Inc. (RXMD) will present at the Emerging Growth Conference on May 26, 2021, at 11:30 AM Eastern time. CEO Alan Jay Weisberg will lead a 30-minute presentation and engage with shareholders and the investment community through a Q&A session. This event allows for real-time interaction and will be accessible online, with an archived webinar available post-event. The Emerging Growth Conference focuses on public companies in various growth sectors, offering a platform to showcase products and services.
FAQ
What is the current stock price of PROGRESSIVE CARE (RXMD)?
What is the market cap of PROGRESSIVE CARE (RXMD)?
What are the core services offered by Progressive Care Inc.?
How does Progressive Care manage its 340B contracts?
What role does tele-pharmacy play in Progressive Care's operations?
How does Progressive Care integrate with NextPlat Corp?
What measures does Progressive Care take to ensure quality and risk management?
Who are the primary customers of Progressive Care Inc.?
How does data management contribute to the company’s success?
What differentiates Progressive Care in the competitive healthcare market?
